awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34531545-F370F3C2-1606-4121-85DD-E38B4BDD5E75
Q34531545-F370F3C2-1606-4121-85DD-E38B4BDD5E75
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34531545-F370F3C2-1606-4121-85DD-E38B4BDD5E75
Safety, tolerability, and efficacy of vortioxetine (Lu AA21004) in major depressive disorder: results of an open-label, flexible-dose, 52-week extension study
P2860
Q34531545-F370F3C2-1606-4121-85DD-E38B4BDD5E75
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34531545-F370F3C2-1606-4121-85DD-E38B4BDD5E75
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ae89cfc195954b9ca5b1f8fe97f1e616eed83c99
P2860
A randomized, double-blind trial of 2.5 mg and 5 mg vortioxetine (Lu AA21004) versus placebo for 8 weeks in adults with major depressive disorder.